Supporting the health of men on probation: Professionals’ experiences of healthcare access and its implications for desistance
Probation Journal · 17.11.2026
DOI: 10.1177/02645505261506947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probation Journal, online erschienen am 17.11.2026. Verfasst von Ella Rabaiotti und 1 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: St. David's Medical Foundation.
Abstract (Originalsprache)
People on probation are increasingly seen as an inclusion health group, characterised by overlapping physical health, mental health and substance use needs, alongside social disadvantage, and leading to significantly poorer health outcomes. This qualitative study is centred on 22 semi-structured interviews with professionals working in probation and health services in Wales to understand practitioner experiences of healthcare for men on probation. Two key themes highlighted in the findings – healthcare barriers and healthcare opportunities – emphasise complex systematic challenges alongside emerging inclusion health practice and development. The authors advocate for an integrated, inclusive approach to address health inequalities and support desistance.
Förderung
- St. David's Medical Foundation
Zitieren
APA
Rabaiotti, E., & Morgan, G. (2026). Supporting the health of men on probation: Professionals’ experiences of healthcare access and its implications for desistance. Probation Journal. https://doi.org/10.1177/02645505261506947
Vancouver
Rabaiotti E, Morgan G. Supporting the health of men on probation: Professionals’ experiences of healthcare access and its implications for desistance. Probation Journal. 2026. doi:10.1177/02645505261506947
BibTeX
@article{Rabaiotti2026,
author = {Rabaiotti, Ella and Morgan, Gemma},
title = {Supporting the health of men on probation: Professionals’ experiences of healthcare access and its implications for desistance},
journal = {Probation Journal},
year = {2026},
doi = {10.1177/02645505261506947}
}
EUVIMED